That's A Double

The price of a drug used to delay birth in women at high risk of delivering prematurely is going to skyrocket following Food and Drug Administration approval of a prescription form of the product, a synthetic form of the hormone progesterone.

Since 2003, the American Congress of Obstetricians and Gynecologists has recommended that doctors offer the progesterone shots to high-risk women. But because there has not been a commercial product available, women have obtained the drug from so-called compounding pharmacies, which make it to order. The pharmacies have typically charged about $10 to $20 per shot for the drug, which is given weekly.

Skyrocket, as it turns out, is a generous term.  The $20 shot will now be $1500.  Per weekly shot, to be clear.   There is mention of significant assistance to make sure it's available to every woman who needs it.  Sure.  What was once affordable and reasonable will now become bloated and unavailable.  Women will no longer be able to afford the medicine, insurance companies will refuse to cover it, and preventable miscarriages will abound.  Nobody wins, except the guys charging 75 times the original cost of the shots. 

That's what we call a double screwing, folks.